Baseline separation of latanoprost and its isomers 15(S)-latanoprost (impurity I) and 5,6-trans-latanoprost (impurity II) has been achieved for the first time by HPLC on an NH2 column with heptane-2-propanol-acetonitrile 93:6:1 (v/v), with addition of a small amount of water, as mobile phase. Validation of the method is described.
[1]. J. Stjernschantz B. Resul 1992 Drugs Fut. 17 691.
[2]. B. Resul J. Stjernschantz K. No Ch. Liljebria G. Selen M. Astin M. Karlsson L.Z. Bito 1993 J. Med. Chem. 36 243.
[3]. S.F.E. Nilsson M. Samuelsson A. Bill J. Stjernschantz 1989 Exp. Eye Res. 48 707.
[4]. B. Sjőquist S. Basu K. Bergh P. Byding 1994 Exp. Eye Res. 59 146.
[5]. M. Abramovitz M. Adam Y. Boie et al.2000 Biochim. Biophys. Acta 1483 285.
[6]. Ch. Linden E. Nuika A. Alm 1997 Brit. J. Ophthalmol. 81 370.
[7]. S. Nagasubramanian G.P. Sheth R.A. Hitchings J. Stjernschantz 1993 Ophthalmology 100 1305.
[8]. Impurities in New Drug Substances. Q3A (R1), International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use.
[9]. A.R. Whorton K. Carr M. Smigel L. Walker K. Ellis J.A. Oates 1979 J. Chromatogr. 163 64.
[10]. S. Ahuja 1989 Selectivity and Detectability Optimization in HPLC John Wiley and Sons New York.
[11]. S.M. Plaised T.A. Zwier B.G. Snider 1983 J. Chromatogr. 281 151.
[12]. V. Radulescu C. Doneanu C. Mandruta F. Cocu 1997 Rev. Roum. Chim. 42 1129.
[13]. M. Ashfaq I.U. Khan M.N. Asghar 2006 Anal. Lett. 39 2235.
[14]. P.V. Morgan S. Proniuk J. Blanchard R.J. Noecker 2001 J. Glaucoma 10 401.